Can a pill shield vulnerable transplant patients from deadly fungus?
NCT ID NCT04725942
Summary
This study looked at whether the drug posaconazole, given as a tablet, can safely prevent serious lung fungal infections in patients who have received a stem cell transplant. It followed 360 transplant patients in China for about 3 months each, checking their blood drug levels and monitoring for infections. The goal was to see how well the drug works and how the body processes it in this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FUNGAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
-
Shanxi Bethune Hospital
Taiyuan, China
-
The Second Hospital of Hebei Medical University
Shijia Zhuang, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Conditions
Explore the condition pages connected to this study.